Cryofibrination: Did it really happen?

Perfusion

Volumn 16, Issue 1, 2001, Pages 83-86

  Luckraz, Heyman ^a   Boolauky, Deobrat ^a   Mohangee, Ahmad ^a  

^a Cardiac Trust Fund   (Mauritius)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; CRYOFIBRIN; FIBRIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CARDIOPULMONARY BYPASS; CARDIOPULMONARY HEMODYNAMICS; CASE REPORT; COOLING; CRYOPRECIPITATION; FIBRIN DEPOSITION; HEAT EXCHANGE; HUMAN; MALE; OXYGENATOR; PRESSURE; PRIORITY JOURNAL;

ADULT; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; CRYOGLOBULINS; DISEASE SUSCEPTIBILITY; EQUIPMENT FAILURE; EXTRACORPOREAL MEMBRANE OXYGENATION; FIBRINOGENS, ABNORMAL; HUMANS; HYPOTHERMIA, INDUCED; INTERNAL MAMMARY-CORONARY ARTERY ANASTOMOSIS; MALE; MEDIASTINUM; MIDDLE AGED; OXYGENATORS, MEMBRANE; POSTOPERATIVE HEMORRHAGE; PRECIPITATION; PRESSURE; SAFETY;

EID: 0035166625     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/026765910101600112     Document Type: Article

References (4)

1. An artificial lung dependent upon diffusion of oxygen and carbon dioxide through plastic membranes
2. Pathologic fibrin formation and cold-induced clotting of membrane oxygenators during cardiopulmonary bypass
3. Albumin in the cardiopulmonary bypass prime: How little is enough?
4. Aspirin acetylates fibrinogen and enhances fibrinolysis. Fibrinolytic effect is independent of changes in plasminogen activator levels